JUL 21, 2017 10:00 AM PDT

WEBINAR: CRISPR/Cas9: Moving from Founder Mice to Phenotyping

Speaker
  • Senior Director, Genetic Engineering, Transgenic Genotyping, and Reproductive Sciences , The Jackson Laboratory
    Biography
      Dr. Grass has been involved in the generation of genetically modified mice for more than 25 years. He received his Ph.D. in Molecular Biology from Columbia University in New York, and was a post doctoral fellow at The Sloan Kettering Institute for Cancer Research, where the focus of his research was molecular immunology. Dr. Grass spent an extensive amount of time at a small biotech company (Xenogen Biosciences, previously known as DNX), where his groups were responsible for genetically modified model generation as well as phenotyping and in vivo compound assessment. Dr. Grass is currently the Senior Director, Genetic Engineering, Transgenic Genotyping, and Reproductive Sciences, with responsibility for the model generation program at the Jackson Laboratory.

    Abstract

    DATE: July 21, 2017
    TIME: 10:00am PT, 1:00pm ET

    CRISPR/Cas9 techniques are quickly growing in popularity for the generation of new mouse models for research. Though the approach is relatively simple, many researchers struggle with understanding the complexities associated with the diverse alleles that can be generated, how to deal with mosaicism, and how to move from a single founder mouse to larger cohorts for phenotype characterization.

    Learning Objectives:

    • Understanding the molecular mechanisms that drive the array of possible mutations that can result from a single Cas9/sgRNA targeting strategy
    • A summary of various common targeting strategies to generate indel, knockout, and knockin mutations using CRISPR/Cas9
    • Selection of founder mice and breeding strategies for mitigating mosaicism in founder mice
    • Breeding strategies to establish a colony and generate cohorts for experimentation

    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources